Editorial
Published on 20 Oct 2022
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1059885
- 1,427 views
- 2 citations
Type at least 3 characters
1,192 articles
Articles
Original Research
Published on 19 Oct 2022
A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.939131
- 2,222 views
- 3 citations
Original Research
Published on 18 Oct 2022
PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1010092
- 4,877 views
- 10 citations
Editorial
Published on 18 Oct 2022
Editorial: Early diagnoses and treatments of uncommon breast cancers
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1042226
- 1,255 views
Original Research
Published on 18 Oct 2022
Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1031798
- 2,513 views
- 3 citations
Review
Published on 17 Oct 2022
Beyond the “3 Ps”: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1029041
- 6,492 views
- 12 citations
Original Research
Published on 17 Oct 2022
Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.973091
- 2,705 views
- 3 citations
Original Research
Published on 14 Oct 2022
Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1030655
- 2,728 views
- 16 citations
Original Research
Published on 14 Oct 2022
A prognostic model for cervical cancer based on ferroptosis-related genes
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.991178
- 3,614 views
- 5 citations
Original Research
Published on 13 Oct 2022
Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1020655
- 1,630 views
- 5 citations
Original Research
Published on 13 Oct 2022
Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.987942
- 5,010 views
- 13 citations
Original Research
Published on 11 Oct 2022
Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.965448
- 2,618 views
- 4 citations
Original Research
Published on 11 Oct 2022
Diagnosis and treatment of liver metastases of parathyroid carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.982972
- 3,440 views
- 5 citations
Original Research
Published on 10 Oct 2022
Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1031210
- 4,471 views
- 7 citations
Original Research
Published on 07 Oct 2022
Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.926491
- 2,548 views
- 3 citations
Mini Review
Published on 06 Oct 2022
Adiponectin: A player in the pathogenesis of hormone-dependent cancers
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1018515
- 3,486 views
- 7 citations